Literature DB >> 22816134

Advances in image-guided intratumoral drug delivery techniques.

Luis Solorio1, Ravi B Patel, Hanping Wu, Tianyi Krupka, Agata A Exner.   

Abstract

Image-guided drug delivery provides a means for treating a variety of diseases with minimal systemic involvement while concurrently monitoring treatment efficacy. These therapies are particularly useful to the field of interventional oncology, where elevation of tumor drug levels, reduction of systemic side effects and post-therapy assessment are essential. This review highlights three such image-guided procedures: transarterial chemoembolization, drug-eluting implants and convection-enhanced delivery. Advancements in medical imaging technology have resulted in a growing number of new applications, including image-guided drug delivery. This minimally invasive approach provides a comprehensive answer to many challenges with local drug delivery. Future evolution of imaging devices, image-acquisition techniques and multifunctional delivery agents will lead to a paradigm shift in patient care.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22816134      PMCID: PMC5568554          DOI: 10.4155/tde.10.20

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  121 in total

Review 1.  Biodegradable injectable in situ forming drug delivery systems.

Authors:  A Hatefi; B Amsden
Journal:  J Control Release       Date:  2002-04-23       Impact factor: 9.776

Review 2.  Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria.

Authors:  Daniel B Brown; Jennifer E Gould; Debra A Gervais; S Nahum Goldberg; Ravi Murthy; Steven F Millward; William S Rilling; Jean-Francois S Geschwind; Riad Salem; Suresh Vedantham; John F Cardella; Michael C Soulen
Journal:  J Vasc Interv Radiol       Date:  2007-12       Impact factor: 3.464

Review 3.  Drug-eluting polymer implants in cancer therapy.

Authors:  Agata A Exner; Gerald M Saidel
Journal:  Expert Opin Drug Deliv       Date:  2008-07       Impact factor: 6.648

4.  Poor drug distribution as a possible explanation for the results of the PRECISE trial.

Authors:  John H Sampson; Gary Archer; Christoph Pedain; Eva Wembacher-Schröder; Manfred Westphal; Sandeep Kunwar; Michael A Vogelbaum; April Coan; James E Herndon; Raghu Raghavan; Martin L Brady; David A Reardon; Allan H Friedman; Henry S Friedman; M Inmaculada Rodríguez-Ponce; Susan M Chang; Stephan Mittermeyer; David Croteau; Raj K Puri
Journal:  J Neurosurg       Date:  2010-08       Impact factor: 5.115

5.  Intratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenografts.

Authors:  Ming Xie; Liang Zhou; Tao Hu; Ming Yao
Journal:  Anticancer Drugs       Date:  2007-04       Impact factor: 2.248

6.  Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization.

Authors:  J V Vitola; D Delbeke; S G Meranze; M J Mazer; C W Pinson
Journal:  Cancer       Date:  1996-11-15       Impact factor: 6.860

7.  Combined tumor therapy by using radiofrequency ablation and 5-FU-laden polymer implants: evaluation in rats and rabbits.

Authors:  John R Haaga; Agata A Exner; Yadong Wang; Nicholas T Stowe; Peter J Tarcha
Journal:  Radiology       Date:  2005-10-19       Impact factor: 11.105

8.  Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma.

Authors:  S Herber; G Otto; J Schneider; N Manzl; I Kummer; S Kanzler; A Schuchmann; J Thies; C Düber; M Pitton
Journal:  Cardiovasc Intervent Radiol       Date:  2007-05-17       Impact factor: 2.740

9.  Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors.

Authors:  Guido Poggi; Pietro Quaretti; Claudio Minoia; Giovanni Bernardo; Mario Regazzi Bonora; Raffaella Gaggeri; Anna Ronchi; Cesare Massa Saluzzo; Andrea Azzaretti; Giuseppe Rodolico; Michela Montagna; Alessio Amatu; Cristina Teragni; Ilaria Palumbo; Elena Traverso; Stefano Tonini; Laura Villani; Mario Scelsi; Paola Baiardi; Maria Grazia Felisi; Federico Sottotetti; Barbara Tagliaferri; Alberto Riccardi
Journal:  Anticancer Res       Date:  2008 Nov-Dec       Impact factor: 2.480

10.  Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality.

Authors:  Swee H Teh; John Christein; John Donohue; Florencia Que; Michael Kendrick; Michael Farnell; Stephen Cha; Patrick Kamath; Raymond Kim; David M Nagorney
Journal:  J Gastrointest Surg       Date:  2005-12       Impact factor: 3.267

View more
  9 in total

1.  Ultrasound-guided intratumoral delivery of doxorubicin from in situ forming implants in a hepatocellular carcinoma model.

Authors:  Luis Solorio; Hanping Wu; Christopher Hernandez; Mihika Gangolli; Agata A Exner
Journal:  Ther Deliv       Date:  2016

2.  Image-guided thermal therapy with a dual-contrast magnetic nanoparticle formulation: A feasibility study.

Authors:  Anilchandra Attaluri; Madhav Seshadri; Sahar Mirpour; Michele Wabler; Thomas Marinho; Muhammad Furqan; Haoming Zhou; Silvia De Paoli; Cordula Gruettner; Wesley Gilson; Theodore DeWeese; Monica Garcia; Robert Ivkov; Eleni Liapi
Journal:  Int J Hyperthermia       Date:  2016-05-05       Impact factor: 3.914

3.  Effect of cargo properties on in situ forming implant behavior determined by noninvasive ultrasound imaging.

Authors:  Luis Solorio; Alexander M Olear; Haoyan Zhou; Ashlei C Beiswenger; Agata A Exner
Journal:  Drug Deliv Transl Res       Date:  2012-02-01       Impact factor: 4.617

4.  Multimodality imaging-guided local injection of eccentric magnetic microcapsules with electromagnetically controlled drug release.

Authors:  Wenwei Huang; Yin Chen; Lanxi Chen; Jinshuang Zhong; Amer M Johri; Jianhua Zhou
Journal:  Cancer Rep (Hoboken)       Date:  2018-12-21

Review 5.  Positron emission tomography image-guided drug delivery: current status and future perspectives.

Authors:  Rubel Chakravarty; Hao Hong; Weibo Cai
Journal:  Mol Pharm       Date:  2014-06-04       Impact factor: 4.939

6.  Intratumoral Administration of a Novel Cytotoxic Formulation with Strong Tissue Dispersive Properties Regresses Tumor Growth and Elicits Systemic Adaptive Immunity in In Vivo Models.

Authors:  Lewis H Bender; Franco Abbate; Ian B Walters
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

7.  Nanoporous Gold Monolith for High Loading of Unmodified Doxorubicin and Sustained Co-Release of Doxorubicin-Rapamycin.

Authors:  Jay K Bhattarai; Dharmendra Neupane; Bishal Nepal; Alexei V Demchenko; Keith J Stine
Journal:  Nanomaterials (Basel)       Date:  2021-01-15       Impact factor: 5.076

8.  Intratumoral Monocyte Transfer to Examine Monocyte Differentiation in the Tumor Microenvironment.

Authors:  Samir Devalaraja; Malay Haldar
Journal:  STAR Protoc       Date:  2020-12-03

9.  Noninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imaging.

Authors:  Luis Solorio; Alexander M Olear; Jesse I Hamilton; Ravi B Patel; Ashlei C Beiswenger; Jon E Wallace; Haoyan Zhou; Agata A Exner
Journal:  Theranostics       Date:  2012-11-08       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.